Are we still treating viruses too late?

Immune system illustration

At the height of COVID, I sent an email to our local hospital.

I offered our clinic — including our staff, our IV infrastructure, and our oxygen capacity — to help triage patients. I proposed something radical at the time: intervene before people crashed. Pilot protocols using high-dose IV vitamin C, correct vitamin D deficiency, support antioxidant systems with glutathione, and address immune dysfunction upstream of respiratory failure.

The response? Nothing. No acknowledgement. No discussion. Just silence.

That moment crystallized something I had known for years but had never seen so starkly exposed: modern medicine is extraordinarily good at rescue, and remarkably poor at immune preparedness.

Five years later, we're still having the wrong conversation, even as mainstream media finally begins to ask better questions. A recent BBC Science Focus cover story framed it plainly: the immune system is not a static shield, but a living, adaptive network that must be supported before it is overwhelmed. Canadian headlines warn of emerging "super-flu" variants that may outpace last year's immunity.

Viral threats evolve, but immune resilience is built — or lost — long before exposure.

Viruses evolve. Our strategy barely has.

Each winter brings new headlines: novel flu variants, immune escape, strain mismatch. Viral mutation is expected. What is far more concerning is how little our strategy evolves in response.

The default medical approach remains: wait for symptoms, suppress fever, manage discomfort, escalate to oxygen when deterioration occurs.

Vaccines and antivirals have a role. But neither replaces the need for immune system integrity — the body's capacity to recognize pathogens, respond appropriately, regulate inflammation, and recover efficiently.

Immune function is shaped daily by sleep, stress, nutrition, circadian rhythms, gut health, and metabolic state — not activated on demand once illness strikes. Yet most medical systems remain organized around crisis response rather than immune cultivation.

Why conventional medicine struggles with viruses.

This is not a criticism of individual physicians. It is a systems problem. Conventional medicine excels at trauma, bacterial infection, surgery, and end-stage disease management. Viruses are different.

There is no equivalent of a broad-spectrum antibiotic for viral illness. Most antivirals are modestly effective, highly time-dependent, and strain-specific. Once viral replication peaks and inflammation dominates, medical care becomes largely supportive. By the time patients are "sick enough," the most meaningful window has often closed.

The immune system lives in the gut.

Approximately 70% of immune tissue resides in the gut-associated lymphoid tissue (GALT). This is foundational immunology. The gut is where immune tolerance is learned, inflammatory responses are calibrated, and microbial signals shape antiviral readiness.

Importantly, the gut also tightly regulates nutrient absorption. Many immune-critical nutrients — vitamin C, zinc, magnesium, and glutathione precursors — cannot reach pharmacologically meaningful serum levels through oral intake alone. Clinically, this often presents as recurrent infections, prolonged viral courses, or exaggerated inflammatory responses.

Why IV and IM nutrient therapy is fundamentally different.

IV and intramuscular nutrient delivery bypasses intestinal regulation entirely, allowing clinicians to raise serum and intracellular nutrient levels to ranges not achievable through oral supplementation.

High-dose IV vitamin C is the clearest example. Oral absorption is saturable — plasma concentrations plateau well below levels shown to influence oxidative stress, endothelial function, and viral defense. In contrast, high-dose IV vitamin C achieves pharmacologic plasma concentrations capable of modulating inflammation and supporting immune cell function.

Glutathione, the body's master antioxidant, plays a central role in immune resilience. Oral glutathione has poor bioavailability; IV directly supports intracellular redox systems.

IM vitamin D allows for rapid repletion in individuals with malabsorption, non-adherence, or acute immune stress.

At our clinic, immune-focused IV formulas such as High-Dose IV Vitamin C, Shield, and Flu Fighter are not "immune boosts." They are delivery systems designed to work within immune physiology.

Botanical medicines: a vast pharmacopoeia, not a footnote.

One of the quiet failures of modern medicine is how thoroughly it has sidelined botanical therapeutics — not because they lack biological activity, but because they resist simplification. There are hundreds of plant medicines with documented antiviral, antimicrobial, and immunomodulatory properties:

  • Echinacea species (immune signaling, NK-cell activation)
  • Zingiber officinale (ginger; antiviral and anti-inflammatory)
  • Ocimum sanctum (holy basil; immunomodulatory and stress-adaptive)
  • Sambucus nigra (elderberry; viral entry inhibition)
  • Astragalus membranaceus (immune tonification)
  • Glycyrrhiza glabra (licorice; antiviral and mucosal protection)
  • Andrographis paniculata — well-studied for reducing severity and shortening duration of viral URIs when used early.

Botanical medicines do not simply "kill" viruses. They influence viral replication, host-cell entry, interferon signaling, and tissue resilience. They act on the biological terrain, not just the pathogen.

Fasting, fever, and forgotten physiology.

Loss of appetite during acute illness is not pathological — it is adaptive. Short-term fasting during early viral infection shifts immune metabolism toward antiviral pathways and reduces inflammatory burden. Fever is not an error either: elevated core temperature inhibits viral replication, enhances immune-cell trafficking, and improves interferon signaling. Aggressive fever suppression may prolong illness.

The immune system knows what it is doing. We frequently interfere when we should be supporting.

The conversation we're committed to leading.

The lesson of COVID was not that we lacked technology. It was that we lacked immune literacy. As viral threats continue to evolve, the answer is not fear, nor passive waiting. The answer is building immune integrity long before the headline hits.

The best time to support your immune system is before you need it to save you.

Immune System IV Therapy Botanical Medicine Cold & Flu Vitamin C

Stay in touch

New writing, in your inbox.

Clinical notes, fresh essays, and the occasional postcard from clinic and grove.